Skip navigation
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

All meetings & conferences

465 meetings & conferences listed on 

2014 Ross Prize in Molecular Medicine: Advances in Immunomodulation
United States
New York

2014 Ross Prize in Molecular Medicine: Advances in Immunomodulation

Monday, June 9, 2014 10:00 AM - 3:15 PM The New York Academy of Sciences

Presented by The Feinstein Institute for Medical Research, Molecular Medicine, and The New York Academy of Sciences

The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine. The Ross Prize recognizes biomedical scientists whose discoveries have changed the way medicine is practiced. The prize is awarded to midcareer scientists who have made a significant impact in the understanding of human disease pathogenesis and/or treatment and who hold significant promise for making even greater contributions to the general field of molecular medicine.

The 2014 Ross Prize in Molecular Medicine will be awarded to Dr. John J. O'Shea for his discoveries in immunology and cytokine biology.

During this symposium, Dr. O'Shea will accept the Ross Prize and reflect upon his early research and ongoing efforts to better understand the role of T cells in host defense and the pathogenesis of autoimmune diseases. Following the award presentation, other leading immunologists will present new research regarding the mechanisms of immune system function and signaling which may improve the treatment for cancer and various autoimmune diseases.

Registration Pricing

Symposium registration is free. Although on-site registration may be possible on the day of the event, pre-registration is highly encouraged due to space limitations.

Immunologist, Oncologist, Physician Researcher, Rheumatologist
13th International Conference on Malignant Lymphoma

13th International Conference on Malignant Lymphoma

June 17-20, 2015 Lugano, Switzerland

The 13th International Conference on Malignant Lymphoma, the most important international forum devoted to basic and clinical research in lymphoid neoplasms, will take place in June 2015. Basic and clinical data will be presented during the sessions, focused not on a specific morphologic subtype, but rather on pathways or other biological aspects (e.g. microenvironment, immune system, chromosomal abnormalities, etc.). New sessions, such as the Educational Symposia, the special sessions devoted to radiotherapy and the ongoing trials presentation, were introduced in 2013 and, thanks to the many positive feedbacks, they will be repeated. Immediately after the Kaplan Lecture, worldwide known experts will discuss the best 3-4 accepted abstracts during a Plenary Session.

Hematologist, Oncologist, Physician Researcher, Radiation Oncologist
Pathology Visions 2014
United States

Pathology Visions 2014

October 20 - 21, 2014 San Francisco, California

The Pathology Visions Conference will give you the opportunity to learn about real-world, practical applications in the ever-evolving field of digital pathology. The Digital Pathology Association’s annual meeting will give you direct access to industry leaders, the opportunity to earn CME credits, your choice of dozens of cutting-edge workshops with distinguished trade visionaries, the chance to see the latest product solutions, and much more.

Pathologist, Physician, Physician Researcher
American Society for Peripheral Nerve 2015 Annual Meeting

American Society for Peripheral Nerve 2015 Annual Meeting

January 23-25, 2015 Atlantis, Paradise Island, Bahamas

Allied Health Professional, Neuroscientist, Neurosurgeon, Orthopedic Surgeon, Physician, Physician Researcher, Plastic Surgeon, Surgeon
American Society for Peripheral Nerve 2015 Annual Meeting

American Society for Peripheral Nerve 2015 Annual Meeting

January 23-25, 2015 Atlantis, Paradise Island, Bahamas

2014 mHealth Summit
United States
Washington, DC

2014 mHealth Summit

December 7-11, 2014 Washington, DC Area

The mHealth Summit, the largest event of its kind, convenes a diverse international delegation to explore the limits of mobile and connected health, including every aspect and every audience from technology, business, research and policy and covering mobile, wireless, digital, wearable, telehealth, gaming, connected health and consumer engagement. Our 6th annual Summit will put new emphasis on innovation and evidence. The world will be here. Won’t you join us?


The mHealth Summit Convenes an Array of Healthcare Stakeholders Focused on the Integration of mHealth and Wireless Solutions to Improve Systemic Healthcare Systems, Patient Outcomes, and Access to care and Customer Satisfaction Including:
A diverse delegation of stakeholders focused on mobile and connected health including:

Healthcare providers and managers of mobile tech: hospitals, clinics, physician networks, health centers, nurse call centers, mobile clinics, VA, rural reach and military theaters of operation

Payers, insurance companies, self-insuring companies, etc.

The technology and developer communities

Public health and healthcare professionals

Pharma, life sciences, researchers and academics

Policy makers

Corporations and businesses

Investors and financial communities

Military servicemen and women



Hear what the experts are thinking about and doing in areas such as:

Evaluating mhealth impacts and lessons learned

Healthcare redesign
Clinical workflow

Global health to improve care access and reduce disparities

Finance models for care delivery and preventive health

Designing clinical trials and redefining customer relationships in the life sciences

Investment models

Economic development

Public health monitoring

Disaster management

Market research 

Computer Scientist, Health Services Researcher, Informatician, Information Scientist, Nurse, Physician, Public Health Expert, Technologist
Eleventh International Kawasaki Disease Symposium
United States

Eleventh International Kawasaki Disease Symposium

Feb. 3-6, 2015 Honolulu, Hawaii

This 3 ½ day conference includes lectures, discussions, and oral/poster presentations focusing on the latest advances in Kawasaki disease. Kawasaki disease is the major cause of acquired childhood heart disease in developed countries. Children who develop significant coronary artery aneurysms as a result of Kawasaki disease have a lifetime increased risk of myocardial ischemia, infarction, and sudden death. The study of Kawasaki disease and its treatment are likely to yield important answers to general questions in cardiovascular health and disease that apply equally to pediatric and adult populations.

The Eleventh International Kawasaki Disease Symposium seeks to address the influence of genetics on disease susceptibility and outcomes, the mechanisms of coronary artery damage following severe acute inflammation, the role of immune modulation and other novel therapies in preventing artery damage, the potential use of serum biomarkers for diagnosis and prognosis, the use of newer imaging techniques to assess abnormalities of the coronary arteries and myocardium, and new therapies regarding anticoagulation and vascular health. Current data regarding the worldwide epidemiology will be highlighted, as well as psychosocial issues, guidelines and nursing practice .

Since the historic first International Kawasaki Disease Symposium in 1984, the international symposium has been held every 3 years in Japan, the United States, or Taiwan, drawing attendees from all continents.

Who Should Attend -  The audience will consist of pediatric and adult cardiologists, pediatricians and pediatric subspecialists in immunology, infectious disease, and rheumatology;  cardiovascular surgeons; pathologists; basic scientists in genetics, molecular biology, microbiology, and cardiovascular pathophysiology; public health officials from county and state agencies and the Center for Disease Control and Prevention; epidemiologists; and nurses working in pediatric cardiology and public health who have an interest in Kawasaki disease.


Summarize prevailing hypotheses regarding KD etiology, and discuss emerging research supporting or contradicting these hypotheses.

Summarize current findings regarding diagnostic and prognostic biomarkers for KD, and their potential significance to clinical practice.

Summarize the most recent research and clinical findings regarding genetic susceptibility to KD and to KD coronary artery disease.

Summarize the most recent research and clinical findings regarding IVIG mechanism of action and the efficacy of additional or alternative therapies

Review evidence regarding the two distinct arterial processes that can lead to myocardial ischemia or infarction.

Review available imaging modalities for their ability to assess for presence of thrombosis and luminal myofibroblastic proliferation.

Summarize technical principles and current evidence supporting use of various imaging modalities in determining KD prognosis and optimal long-term follow-up.

Review evidence regarding the efficacy, safety, and long-term expected outcomes of revascularization options for KD patients.

Review current understanding, recent findings, and unresolved issues regarding optimization of thromboprophylaxis in KD patients.

Cardiologist, Cardiothoracic Surgeon, Epidemiologist, Microbiologist, Molecular Biologist, Pathologist, Patient, Pediatrician, Public Health Expert, Public Health Worker, Surgeon
53rd Annual Meeting of the American College of Neuropsychopharmacology
United States

53rd Annual Meeting of the American College of Neuropsychopharmacology

December 7 - 11, 2014 Phoenix, Arizona

The 53rd Annual Meeting of the American College of Neuropsychopharmacology will be held from December 7 - 11 in Phoenix, Arizona, at the JW Marriott Desert Ridge. The ACNP Annual Meeting is one of the world's leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs.

The ACNP Annual Meeting is open only to members and their invited guests.

Physician, Physician Researcher, Psychiatrist
6th Annual Health Literacy Research Conference
United States

6th Annual Health Literacy Research Conference

November 3-4, 2014 Bethesda, Maryland

The Health Literacy Annual Research Conference is an interdisciplinary meeting for investigators dedicated to health literacy research.  It is an opportunity to advance the field of health literacy, a method to raise the quality of our research, and a venue for professional development.

Our aim is to attract a full range of investigators engaged in health literacy research including those involved in a broad array of public health, health services, epidemiology, translational, and interventional research activities.

Epidemiologist, Health Educator, Health Services Researcher, Nurse Researcher, Public Health Expert, Public Servant
26th Symposium and Annual Meeting of the International Society for Ceramics in Medicine (BIOCERAMICS 26)

26th Symposium and Annual Meeting of the International Society for Ceramics in Medicine (BIOCERAMICS 26)

November 6-8, 2014 Barcelona, Spain

The purpose of the Bioceramics annual meetings is to bring together researchers and clinicians, in order to establish an open forum for presentation and discussion of the latest advances in the field of bioceramics research and their medical applications.

The conference will include sessions on new processing routes for bioceramics and biocomposites, surface engineering and bioceramic coatings, biomineralisation and biomimetics, bioceramics for drug delivery, tissue engineering and regenerative medicine, cell and tissue interactions and clinical applications of bioceramics in dentistry and orthopaedics.

Bioengineer, Dentist, Orthopedist, Physician Researcher